NCT00920517
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +8 more
- Locations
-
- Center for Immunization Research Baltimore, Maryland, United States
Clinical trial condition
Arbovirus Infections
Explore clinical trials studying Arbovirus Infections. Study availability and eligibility vary by location and protocol.
474 public trials
45 recruiting studies
Arbovirus Infections trial results
NCT01073306
- Conditions
- Arbovirus Infections, Dengue, Dengue Virus, +9 more
- Locations
-
- Johns Hopkins Project SAVE, Center for Immunization Research Washington D.C., District of Columbia, United States
NCT00919178
- Conditions
- Arbovirus Infections, Dengue, Dengue Hemorrhagic Fever, +10 more
- Locations
-
- Center for Immunization Research, Johns Hopkins School of Public Health Baltimore, Maryland, United States
- University of Vermont Vaccine Testing Center Burlington, Vermont, United States
NCT01072786
- Conditions
- Arbovirus Infections, Dengue, Flaviviridae Infections, +8 more
- Locations
-
- Center for Immunization Research, Johns Hopkins School of Public Health Washington D.C., District of Columbia, United States
- Center for Immunization Research, Johns Hopkins School of Public Health Baltimore, Maryland, United States
- Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC) Burlington, Vermont, United States
- University of Vermont Vaccine Testing Center Burlington, Vermont, United States
NCT01084291
- Conditions
- Arbovirus Infections, Dengue, Dengue Virus, +9 more
- Locations
-
- Fletcher Allen Health Care (FAHC) General Clinical Research Center (GCRC) Burlington, Vermont, United States
- University of Vermont Vaccine Testing Center Burlington, Vermont, United States
Completed
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy Adults
NCT00712803
- Conditions
- Arbovirus Infections, Dengue, Flaviviridae Infections, +7 more
- Locations
-
- Center for Immunization Research, Johns Hopkins School of Public Health Washington D.C., District of Columbia, United States
- Center for Immunization Research, Johns Hopkins University of Public Health Baltimore, Maryland, United States
Completed
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX
NCT00314145
- Conditions
- Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- Chicago, Illinois, United States
- Shawnee Mission, Kansas, United States
- Missoula, Montana, United States
- Dallas, Texas, United States
NCT00314132
- Conditions
- Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- Burbank, California, United States
- Costa Mesa, California, United States
- Davis, California, United States
- San Francisco, California, United States
NCT00981630
- Conditions
- Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- Herston, Queensland, Australia
- Adelaide, South Australia, Australia
NCT00982137
- Conditions
- Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +19 more
- Locations
-
- Herston, Queensland, Australia